Cognitive Functioning in Adults With Somatic Diseases and General Population From a Biopsychosocial Perspective

NCT ID: NCT06365658

Last Updated: 2026-01-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-03

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to investigate cognitive functioning profiles in adults with neurologically recognized aphasic syndromes and general population.

The study group consist of minimal 600 adults (over 18 y.o.) who will be examined by qualified diagnosticians. Participants will be evaluated with tasks related to the studied variables: memory, learning and language. Furthermore informations regarding past and present health condition will be collected from participants.

The main questions it aims to answer are:

1. What is the profile of memory and learning among polish adults?
2. Do gender and age moderates patterns of memory and learning functioning among polish adults?
3. What is a specific pattern of language functioning in adults with neurologically recognized aphasic syndromes?
4. Do gender moderates specific patterns of language functioning in adults with neurologically recognized aphasic syndromes?

Researchers will compare the following groups of adults:

1. general population/control group
2. with neurologically recognized aphasic syndromes
3. seniors (over 60 y.o.)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aphasia Development, Human Neuropathology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

General population/control group

Polish adults (age 18 to 60 y.o).

Psychological assessment

Intervention Type DIAGNOSTIC_TEST

Psychological assessment of memory, learning and language

Neurologically recognized aphasic syndromes

Polish adults (age 18 to 60 y.o) with neurologically recognized aphasic syndromes.

Psychological assessment

Intervention Type DIAGNOSTIC_TEST

Psychological assessment of memory, learning and language

Seniors (over 60 y.o)

Polish adults (over 60 y.o.)

Psychological assessment

Intervention Type DIAGNOSTIC_TEST

Psychological assessment of memory, learning and language

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Psychological assessment

Psychological assessment of memory, learning and language

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age from 18 to 60 y.o.


* age above 18 y.o.
* neurologically recognized aphasic syndromes


* age above 60 y.o.

Exclusion Criteria

* age less then 18 y.o.
* neurologically recognized aphasic syndromes


* age less then 18 y.o.
* no neurologically recognized aphasic syndromes


* age less then 60 y.o.
* diseases of the nervous system, such as: stroke, craniocerebral trauma, neuroinfections, neurodegenerative diseases
* mental disorders such as depression, psychotic disorders, anxiety disorders, addictions
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bartosz M. Radtke

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bartosz M. Radtke

CEO

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Urszula Sajewicz-Radtke, Ph.D.

Role: STUDY_DIRECTOR

Laboratory of Psychological and Educational Tests

Bartosz M Radtke, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Laboratory of Psychological and Educational Tests

Ariadna Łada-Maśko, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Laboratory of Psychological and Educational Tests

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Laboratory of Psychological and Educational Tests

Gdansk, Pomeranian Voivodeship, Poland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Poland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rafał Nowicki, M.A.

Role: CONTACT

+48509805591

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rafał Nowicki, M.A.

Role: primary

+48509805591

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/PTPiP/1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.